{"id":"https://openalex.org/W6999864801","doi":null,"title":"Discovery of multi-target probes for neurodegenerative diseases via ligand design","display_name":"Discovery of multi-target probes for neurodegenerative diseases via ligand design","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W6999864801"},"language":"en","primary_location":{"id":"pmh:oai:cris.unibo.it:11585/134738","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11585/134738","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"BOLOGNESI, MARIA LAURA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"BOLOGNESI, MARIA LAURA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.46843434,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.39989998936653137,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.39989998936653137,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.3630000054836273,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.22030000388622284,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multi-target-drugs","display_name":"multi-target drugs","score":0.9430000185966492},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.8830000162124634},{"id":"https://openalex.org/keywords/ligand-based-drug-design","display_name":"ligand-based drug design","score":0.8859999775886536},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9470000267028809},{"id":"https://openalex.org/keywords/prion-disease","display_name":"prion disease","score":0.9850000143051147},{"id":"https://openalex.org/keywords/fragment-based-drug-discovery","display_name":"fragment-based drug discovery","score":0.6399999856948853},{"id":"https://openalex.org/keywords/hit-identification","display_name":"hit identification","score":0.4440000057220459},{"id":"https://openalex.org/keywords/hit-optimization","display_name":"hit optimization","score":0.7730000019073486},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.625}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7124999761581421},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.5536999702453613},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5529000163078308},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48080000281333923},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45969998836517334},{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.4219000041484833},{"id":"https://openalex.org/C192071366","wikidata":"https://www.wikidata.org/wiki/Q2991682","display_name":"Drug design","level":2,"score":0.40639999508857727},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.4009999930858612},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3758000135421753},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35440000891685486},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3488999903202057},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.32670000195503235},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3190999925136566},{"id":"https://openalex.org/C2989108626","wikidata":"https://www.wikidata.org/wiki/Q904407","display_name":"Drug target","level":2,"score":0.31529998779296875},{"id":"https://openalex.org/C204171352","wikidata":"https://www.wikidata.org/wiki/Q6545861","display_name":"Ligand efficiency","level":4,"score":0.31529998779296875},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.31470000743865967},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3012000024318695},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2856999933719635},{"id":"https://openalex.org/C99726746","wikidata":"https://www.wikidata.org/wiki/Q906396","display_name":"Chemical space","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2745000123977661},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.26260000467300415},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.251800000667572},{"id":"https://openalex.org/C3020370484","wikidata":"https://www.wikidata.org/wiki/Q332154","display_name":"Aged population","level":3,"score":0.2442999929189682},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.23890000581741333},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.2296999990940094},{"id":"https://openalex.org/C2164484","wikidata":"https://www.wikidata.org/wiki/Q5170150","display_name":"Core (optical fiber)","level":2,"score":0.22619999945163727},{"id":"https://openalex.org/C3017438360","wikidata":"https://www.wikidata.org/wiki/Q11188","display_name":"Global population","level":3,"score":0.22220000624656677},{"id":"https://openalex.org/C2986762682","wikidata":"https://www.wikidata.org/wiki/Q964754","display_name":"Basic research","level":2,"score":0.21889999508857727},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.21860000491142273},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.21230000257492065},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.20810000598430634},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.2004999965429306},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.19760000705718994},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.18960000574588776},{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.186599999666214},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.18299999833106995},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.17569999396800995},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.1737000048160553},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.17249999940395355},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.17239999771118164}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:cris.unibo.it:11585/134738","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11585/134738","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7058301454","https://openalex.org/W1981775239","https://openalex.org/W2808734797","https://openalex.org/W4382123622","https://openalex.org/W2048667034","https://openalex.org/W2409241598","https://openalex.org/W2346625028","https://openalex.org/W2914769925","https://openalex.org/W2144472252","https://openalex.org/W2791201138"],"abstract_inverted_index":{"The":[0],"multifactorial":[1],"nature":[2],"of":[3,11,40,48,86,116,124,137,206,209,221,284,326],"major":[4],"neurodegenerative":[5,248],"diseases":[6,32],"and":[7,44,84,98,113,225,301,319],"the":[8,12,19,38,41,67,74,82,108,110,130,135,141,218],"current":[9],"failures":[10],"different":[13],"drugs":[14,89],"in":[15,50,57,81,106,140,159],"clinical":[16],"trials":[17],"represent":[18],"logical":[20],"foundation":[21],"for":[22,287],"a":[23,45,160,166],"multi-target":[24,88],"drug":[25,60,100,273],"discovery":[26,83,101,220],"approach":[27,132],"to":[28,155,170,190,195,217,246,272],"combat":[29,247],"these":[30,128],"devastating":[31],"[1].":[33],"\\nAs":[34],"additional":[35],"positive":[36],"points,":[37],"simplification":[39],"therapeutic":[42],"regimen":[43],"lower":[46],"risk":[47],"polypharmacy":[49],"geriatric":[51],"population":[52],"further":[53],"strengthen":[54],"its":[55],"validity":[56],"comparison":[58],"with":[59,173,193],"combinations":[61],"[2].":[62],"However,":[63],"at":[64],"this":[65],"moment":[66],"afore-mentioned":[68],"advantages":[69],"can":[70,185],"be":[71,191],"outweighed":[72],"by":[73,78,181],"difficulties":[75],"still":[76,118,134],"experienced":[77],"medicinal":[79],"chemists":[80],"development":[85],"novel":[87],"(MTDs).":[90],"In":[91,143],"fact,":[92],"albeit":[93],"methods":[94],"such":[95],"as":[96,187],"fragment-based":[97],"computational":[99],"are":[102,153],"showing":[103],"promising":[104],"potential":[105],"accelerating":[107],"process,":[109],"hit":[111],"identification":[112],"optimization":[114],"stages":[115],"MTDs":[117,222],"poses":[119],"more":[120,176],"challenges":[121],"than":[122,177],"those":[123],"single-target":[125],"drugs.":[126],"Besides":[127],"methods,":[129],"ligand-based":[131],"is":[133],"method":[136],"choice,":[138],"especially":[139],"academia.":[142],"most":[144],"cases,":[145],"two":[146],"starting":[147],"structures":[148],"and/or":[149],"their":[150],"pharmacophoric":[151],"elements":[152],"combined":[154],"incorporate":[156],"both":[157,207],"activities":[158],"new":[161,270],"single":[162,167],"chemical":[163],"entity.":[164],"Alternatively,":[165],"fragment":[168],"able":[169],"recognize":[171],"even":[172],"modest":[174],"affinity":[175,198],"one":[178],"target":[179],"(dubbed":[180],"us":[182],"\u201cuniversal":[183],"template\u201d)":[184],"serve":[186],"core":[188],"scaffold":[189],"decorated":[192],"appendages":[194],"generate":[196],"higher":[197],"compounds":[199],"[3].":[200],"Herein,":[201],"we":[202],"discuss":[203],"several":[204],"examples":[205],"types":[208],"compounds,":[210],"taken":[211],"from":[212],"our":[213],"own":[214],"research":[215],"devoted":[216],"rational":[219],"against":[223],"Alzheimer\u2019s":[224],"prion":[226],"diseases.":[227,249],"\\n\\n[1]":[228],"Cavalli,":[229],"A.;":[230,235,263],"Bolognesi,":[231,257,293],"M.":[232,258],"L.;":[233,259],"Minarini,":[234,262],"Rosini,":[236,264],"M.;":[237,241,265],"Tumiatti,":[238],"V.;":[239],"Recanatini,":[240],"Melchiorre,":[242,266,295],"C.":[243,267,320],"Multi-target-directed":[244],"ligands":[245],"J.":[250,316],"Med.":[251],"Chem.,":[252],"2008,":[253],"51,":[254],"347-72.":[255],"\\n[2]":[256],"Matera,":[260],"R.;":[261],"Alzheimer's":[268],"disease:":[269],"approaches":[271],"discovery.":[274],"Curr":[275],"Opin":[276],"Chem":[277],"Biol,":[278],"2009,":[279],"13,":[280],"303-8.":[281],"\\n[3]":[282],"Discovery":[283,307],"Multi-Target":[285,312],"Agents":[286],"Neurological":[288],"Diseases":[289],"via":[290],"Ligand":[291],"Design.":[292],"M.L.,":[294],"C.,":[296],"Van":[297],"der":[298],"Schyf,":[299],"C.J.,":[300],"Youdim,":[302],"M.B.H.":[303],"in:":[304],"RSC":[305],"Drug":[306],"Series":[308],"No.":[309],"21,":[310],"Designing":[311],"Drugs.":[313],"Edited":[314],"by:":[315],"Richard":[317],"Morphy":[318],"John":[321],"Harris,":[322],"2012,":[323],"Royal":[324],"Society":[325],"Chemistry,":[327],"United":[328],"Kingdom,":[329],"pp.":[330],"290-315":[331]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}